Testing a new method to find early pancreatic cancer in high-risk people
Part of Cancer clinical trials.
This study is testing a new imaging method called LINFU® to see if it can find pancreatic cancer early in people who are at higher risk but have no symptoms. If you are at elevated risk for pancreatic cancer and are already getting imaging tests, this study may help improve early detection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 89 years old
- You must have known risk factors for pancreatic cancer, such as family history or certain genetic conditions
- You must not have any symptoms of pancreatic cancer
- You must be scheduled for or have had an imaging test (like an endoscopic ultrasound, MRI, or CT scan) within the past 90 days
- You cannot have certain medical conditions that would make the LINFU® procedure unsafe, like a bleeding disorder or severe heart or lung problems
- You must not be pregnant and must be able to give informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks for markers in tumor tissue that could help find pancreatic cancer earlier. You may be able to join if you are having surgery for a suspected pancreatic tumor and the final diagnosis is a precancerous condition or pancreatic cancer.
This study follows patients with a type of pancreatic cyst called IPMN who receive the LINFU procedure, a treatment that uses sound waves and microbubbles. Researchers want to see how well it works and monitor safety.
This study tests a special MRI scan and blood tests to see if they can detect early pancreatic cancer in people with high-risk pancreatic cysts called IPMNs. It may help identify cancer earlier, when treatment is more likely to work.
This early-phase trial is testing a new endoscopic (from inside the stomach) approach for pancreatic ductal adenocarcinoma that is locally advanced and cannot be removed with surgery. It may help some people who have already tried first chemotherapy and still have a tumor confined to the pancreas area (no spread).
This study tests LINFU™, a noninvasive method to collect pancreatic cells to help detect pancreatic cancer earlier. You may be invited if you’re at higher risk or you have concerning symptoms and planned pancreas/bile testing (like EUS or CT).
This trial is studying a new screening method (LINFU®) to find pancreatic cancer early in people who have no symptoms or known risk factors, to see if it can help detect cancer in the general population.
Hear when a new Pancreatic Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.